Jazz Pharmaceuticals plc Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Jazz Pharmaceuticals plc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
  • Jazz Pharmaceuticals plc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $59.8M, a 6.5% increase year-over-year.
  • Jazz Pharmaceuticals plc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $231M, a 1.98% decline year-over-year.
  • Jazz Pharmaceuticals plc annual Share-based Payment Arrangement, Expense for 2023 was $227M, a 2.18% increase from 2022.
  • Jazz Pharmaceuticals plc annual Share-based Payment Arrangement, Expense for 2022 was $222M, a 17.5% increase from 2021.
  • Jazz Pharmaceuticals plc annual Share-based Payment Arrangement, Expense for 2021 was $189M, a 56.2% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $227M +$4.85M +2.18% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $222M +$33M +17.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $189M +$68M +56.2% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $121M +$10.4M +9.44% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $111M +$8.12M +7.93% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $102M -$4.46M -4.17% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-23
2017 $107M +$8.13M +8.23% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-25
2016 $98.8M +$7.22M +7.89% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2015 $91.6M +$21.9M +31.5% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 $69.6M +$25.1M +56.3% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 $44.6M +$21.5M +93.6% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-23
2012 $23M +$2.3M +11.1% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-24
2011 $20.7M +$12.5M +152% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-25
2010 $8.22M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.